Anti CCR4 pAb (ATL-HPA031613)
Atlas Antibodies
- SKU:
- ATL-HPA031613-25
- Shipping:
- Calculated at Checkout
$395.00
Gene Name: CCR4
Alternative Gene Name: CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000047898: 77%, ENSRNOG00000010315: 81%
Entrez Gene ID: 1233
Uniprot ID: P51679
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Product Specifications | |
Application | IHC |
Reactivity | Human |
Clonality | Polyclonal |
Host | Rabbit |
Immunogen | LQIYSADTPSSSYTQSTMDHDLHDAL |
Gene Sequence | LQIYSADTPSSSYTQSTMDHDLHDAL |
Gene ID - Mouse | ENSMUSG00000047898 |
Gene ID - Rat | ENSRNOG00000010315 |
Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
Documents & Links for Anti CCR4 pAb (ATL-HPA031613) | |
Datasheet | Anti CCR4 pAb (ATL-HPA031613) Datasheet (External Link) |
Vendor Page | Anti CCR4 pAb (ATL-HPA031613) at Atlas Antibodies |
Documents & Links for Anti CCR4 pAb (ATL-HPA031613) | |
Datasheet | Anti CCR4 pAb (ATL-HPA031613) Datasheet (External Link) |
Vendor Page | Anti CCR4 pAb (ATL-HPA031613) |
Citations for Anti CCR4 pAb (ATL-HPA031613) – 2 Found |
Kurashige, Takashi; Murao, Tomomi; Mine, Naoko; Sugiura, Tomohito; Inazuka, Yukiko; Kuraoka, Kazuya; Takahashi, Tetsuya; Maruyama, Hirofumi; Torii, Tsuyoshi. Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations. Journal Of Neuropathology And Experimental Neurology. 2020;79(4):448-457. PubMed |
Kolben, Thomas; Mannewitz, Mareike; Perleberg, Carolin; Schnell, Konstantin; Anz, David; Hahn, Laura; Meister, Sarah; Schmoeckel, Elisa; Burges, Alexander; Czogalla, Bastian; Hester, Anna; Mahner, Sven; Kessler, Mirjana; Jeschke, Udo; Corradini, Stefanie; Trillsch, Fabian; Beyer, Susanne. Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells. Cellular Oncology (Dordrecht). 2022;45(6):1171-1185. PubMed |